当前位置: X-MOL 学术Allergy Asthma Clin. Immunol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
An emerging allergen: Cannabis sativa allergy in a climate of recent legalization.
Allergy, Asthma & Clinical Immunology ( IF 2.7 ) Pub Date : 2020-06-26 , DOI: 10.1186/s13223-020-00447-9
Bradley Jackson 1 , Erica Cleto 2 , Samira Jeimy 3, 4
Affiliation  

Considering its recent legalization in Canada, the health implications of Cannabis sativa exposure, including allergy, are coming to the forefront of medical study and interest. C. sativa allergy is an issue that affects recreational users of the substance, processors, agricultural workers, and contacts of Cannabis aeroallergens and secondhand product. Allergies to C. sativa are heterogenous and span the spectrum of hypersensitivity, from dermatitis to rhinoconjunctivitis to life-threatening anaphylaxis. Due to its recent legalization, sensitized individuals will have increasing exposure from direct contact to agricultural pollens. Diagnosis and treatment of Cannabis allergy are developing fields that are already showing promise in the identification of culprit antigens and the potential for immunotherapy; however, much responsibility still falls on clinical diagnosis and symptom management. Hopefully, given the current explosion of interest in and use of Cannabis, C. sativa allergy will continue to garner awareness and therapeutic strategies.

中文翻译:

一种新兴的过敏原:在最近合法化的环境中对大麻的过敏。

考虑到其最近在加拿大的合法化,大麻过敏对健康的影响,包括变态反应,已成为医学研究和关注的热点。苜蓿弯曲杆菌过敏是影响该物质的休闲使用者,加工者,农业工人以及大麻气敏原和二手产品接触的问题。苜蓿对苜蓿的过敏是异质性的,并且涉及超敏反应的范围,从皮炎到鼻结膜炎再到威胁生命的过敏反应。由于其最近的合法化,敏锐的个人将直接接触农业花粉的风险不断增加。大麻过敏的诊断和治疗正在发展,这些领域已经在鉴别罪魁祸首抗原和免疫疗法的潜力方面显示出了希望。然而,临床诊断和症状管理仍然有很多责任。希望,鉴于当前对大麻的兴趣和使用激增,苜蓿丝囊菌过敏症将继续获得认识和治疗策略。
更新日期:2020-06-26
down
wechat
bug